Autologous haematopoietic stem cell transplantation for Crohn’s disease: A retrospective survey of long-term outcomes from the European Society for Blood and Marrow Transplantation
<strong>Background and Aims</strong> Autologous haematopoietic stem cell transplantation [AHSCT] is a therapeutic option for patients with severe, treatment-refractory Crohn’s disease [CD]. The evidence base for AHSCT for CD is limited, with one randomised trial [ASTIC] suggesting benefi...
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado: |
Oxford University Press
2018
|